CARLOS ALBAN Insider Trading $ABBV AbbVie Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CARLOS ALBAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARLOS ALBAN. CARLOS ALBAN is Senior Vice President in ABBOTT LABORATORIES ($ABT) and EVP, Commercial Operations in AbbVie Inc. ($ABBV) and Vice Chairman in AbbVie Inc. ($ABBV).
CARLOS ALBAN in AbbVie Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARLOS ALBAN: Vice Chairman, EVP, Commercial Operations
Holdings: 230,729 shares
Current Value: $13,993,714
Latest Transaction: Nov 18 2020
$ABBV Market Capitalization: $98.42B
$ABBV Previous Close: $60.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CARLOS ALBAN in AbbVie Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Option Exercise | M | 35.88 | 115,830 | 4,155,980 | 0 | |
| Nov 18 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Sell | S | 100.00 | 115,830 | 11,583,000 | 114,899 | 230.7 K to 114.9 K (-50.20 %) |
| Nov 18 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Buy | M | 35.88 | 115,830 | 4,155,980 | 230,729 | 114.9 K to 230.7 K (+100.81 %) |
| Jul 08 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Sell | S | 100.00 | 23,000 | 2,300,000 | 114,899 | 137.9 K to 114.9 K (-16.68 %) |
| Jul 08 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Sell | S | 100.00 | 30,325 | 3,032,555 | 137,899 | 168.2 K to 137.9 K (-18.03 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Option Exercise | A | 93.50 | 114,566 | 10,711,921 | 114,566 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 10,125 | 0 | 200,316 | 190.2 K to 200.3 K (+5.32 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 8,214 | 0 | 190,191 | 182 K to 190.2 K (+4.51 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 14,340 | 0 | 181,977 | 167.6 K to 182 K (+8.55 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 39,760 | 0 | 167,637 | 127.9 K to 167.6 K (+31.09 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Option Exercise | A | 79.02 | 62,305 | 4,923,341 | 62,305 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 8,215 | 0 | 152,002 | 143.8 K to 152 K (+5.71 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 14,340 | 0 | 143,787 | 129.4 K to 143.8 K (+11.08 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 13,350 | 0 | 129,447 | 116.1 K to 129.4 K (+11.50 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | ALBAN CARLOS | Vice Chairman | Grant | A | 0.00 | 18,545 | 0 | 116,097 | 97.6 K to 116.1 K (+19.01 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 29.23 | 48,100 | 1,405,795 | 0 | |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 114.43 | 14,829 | 1,696,850 | 97,552 | 112.4 K to 97.6 K (-13.20 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 114.63 | 46,997 | 5,387,463 | 112,381 | 159.4 K to 112.4 K (-29.49 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 113.75 | 19,169 | 2,180,495 | 159,378 | 178.5 K to 159.4 K (-10.74 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 29.23 | 48,100 | 1,405,795 | 178,547 | 130.4 K to 178.5 K (+36.87 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 117.85 | 2,579 | 303,928 | 130,447 | 133 K to 130.4 K (-1.94 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 118.26 | 25,976 | 3,071,922 | 133,026 | 159 K to 133 K (-16.34 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 114.36 | 44,430 | 5,081,015 | 44,430 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 14,340 | 0 | 159,002 | 144.7 K to 159 K (+9.91 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 16,567 | 0 | 144,662 | 128.1 K to 144.7 K (+12.93 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 13,350 | 0 | 128,950 | 115.6 K to 129 K (+11.55 %) |
| Jun 15 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 24.21 | 45,800 | 1,108,736 | 0 | |
| Jun 15 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 70.00 | 45,800 | 3,206,000 | 114,745 | 160.5 K to 114.7 K (-28.53 %) |
| Jun 15 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 24.21 | 45,800 | 1,108,736 | 160,545 | 114.7 K to 160.5 K (+39.91 %) |
| May 08 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 67.00 | 43,000 | 2,881,000 | 114,745 | 157.7 K to 114.7 K (-27.26 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 61.36 | 95,750 | 5,875,220 | 95,750 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 13,350 | 0 | 192,466 | 179.1 K to 192.5 K (+7.45 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 29,672 | 0 | 179,116 | 149.4 K to 179.1 K (+19.85 %) |
| May 12 2016 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 63.52 | 47,438 | 3,013,262 | 149,444 | 196.9 K to 149.4 K (-24.09 %) |
| Mar 02 2016 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 56.00 | 39,930 | 2,236,080 | 196,882 | 236.8 K to 196.9 K (-16.86 %) |
| Feb 22 2016 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 54.86 | 79,870 | 4,381,668 | 79,870 | |
| Mar 03 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 60.50 | 7,200 | 435,600 | 236,812 | 244 K to 236.8 K (-2.95 %) |
| Mar 03 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 60.52 | 12,706 | 768,967 | 244,012 | 256.7 K to 244 K (-4.95 %) |
| Feb 23 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 58.88 | 101,960 | 6,003,405 | 101,960 | |
| Feb 23 2015 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 51,580 | 0 | 256,718 | 205.1 K to 256.7 K (+25.14 %) |
Page: 1